Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/7/2018
SIETES contiene 92427 citas

 
 
 1 a 20 de 1144 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Mitjà O, Godornes C, Houinei W, Kapa A, Paru R, Abel H, González-Beiras C, Bieb SV, Wangi J, Barry AE, Sanz S, Bassat Q, Lukehart SA. Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study. Lancet 2018;391:21 de abril. [Ref.ID 102568]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Šmajs D, Pospíšilová P. Macrolide resistance in yaws. Lancet 2018;391:21 de abril. [Ref.ID 102567]
4. Cita con resumen
Anónimo. Clozapina: modificación del programa de seguimiento de los pacientes. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2017:4 de octubre. [Ref.ID 102091]
6. Cita con resumen
Zhang H, Plutzky J, Shubina M, Turchin A. Continued statin prescriptions after adverse reactions and patient outcomes: a cohort study. Ann Intern Med 2017;167:221-7. [Ref.ID 102037]
7. Cita con resumen
Young LA, Buse JB, Weaver MA, Vu MB, Mitchell M, Blakeney T, Grimm K, Rees J, Niblock F, Donahue KE, for the Monitor Trial Group. Glucose self-monitoring in non-insulin-treated patients with type 2 diabetes in primary care settings. A randomized trial. JAMA Intern Med 2017;177:920-9. [Ref.ID 102017]
8. Cita con resumen
Lehto M, Niiranen J, Korhonen P, Mehtälä J, Khanfir H, Hoti F, Lassila R, Raatikainen P. Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry. Pharmacoepidemiol Drug Saf 2017;26:657-65. [Ref.ID 101963]
9.Enlace a cita original Cita con resumen
Yasmina A, de Boer A, Deneer VHM, Souverein PC, Klungel OH. Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period. Br J Clin Pharmacol 2017;83:632-41. [Ref.ID 101464]
10.Enlace a cita original Cita con resumen
Zong G, Li Y, Wanders AJ, Alssema M, Zock PL, Willett WC, Hu FB, Sun Q. Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies. BMJ 2016;355:i5796. [Ref.ID 100999]
11. Cita con resumen
Rawshani A, Svensson A-M, Zethelius B, Eliasson B, Rosengren A, Gudbjömsdottir S. Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes. JAMA Intern Med 2016;176:1146-54. [Ref.ID 100702]
12. Cita con resumen
13. Cita con resumen
Utter GH, Dhillon TS, Salcedo ES, Shouldice DJ, Reynolds CL, Humphries MD, White RH. Therapeutic anticoagulation for isolated calf deep vein thrombosis. JAMA Surgery 2016:20 de julio. [Ref.ID 100578]
14.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dart RC, Green JL. The prescription paradox of acetaminophen safety. Pharmacoepidemiol Drug Saf 2016;25:599-601. [Ref.ID 100266]
15.Enlace a cita originalTiene citas relacionadas Cita con resumen
Major JM, Zhou EH, Wong H-L, Trinidad JP, Pham TM, Mehta H, Ding Y, Staffa JA, Iyasu S, Wang C, Willy ME. Trends in rates of acetaminophen-related adverse events in the United States. Pharmacoepidemiol Drug Saf 2016;25:590-8. [Ref.ID 100265]
16. Cita con resumen
Bloechliger M, Ceschi A, Rüegg S, Kupferschmidt H, Kraehenbuehl S, Jick SS, Meier CR, Bodmer M. Risk of seizures associated with antidepressant use in patients with depressive disorder: follow-up study with a nested case-control analysis using the clinical practice research datalink. Drug Saf 2016;39:307-21. [Ref.ID 100176]
17. Cita con resumen
Cohen D. Rivaroxaban: can we trust the evidence?. BMJ 2016;352:i575. [Ref.ID 100048]
18.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
19. Cita con resumen
Hupin D, Roche F, Gremeaux V, Chatard JC, Oriol M, Gaspoz JM, Barthélémy JC, Edouard P. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged =60 years: a systematic review and meta-analysis. Br J Sports Med 2015;49:1262-7. [Ref.ID 99458]
Seleccionar todas
 
 1 a 20 de 1144 siguiente >>